Sandoz teams with Evotec in long-term biosim pact - FiercePharma
As Novartis’ Sandoz unit prepares to go it alone, the off-patent medicines specialist is buckling up for the biosimilars long haul. Sandoz on Tuesday struck an accord with Just – Evotec Biologics ...
Read more